clarithromycin has been researched along with streptomycin in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (12.24) | 18.2507 |
2000's | 17 (34.69) | 29.6817 |
2010's | 23 (46.94) | 24.3611 |
2020's | 3 (6.12) | 2.80 |
Authors | Studies |
---|---|
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T | 1 |
Mima, T; Schweizer, HP | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Bohnert, JA; Karamian, B; Nikaido, H | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dekio, S; Hidaka, T; Kawahara, S; Saito, H; Sato, K; Tomioka, H | 1 |
Böttger, EC | 1 |
Hasegawa, N; Kanazawa, M; Kawashiro, T; Sakamaki, F; Terashima, T | 1 |
Brown, BA; Girard, WM; Griffith, DE; Murphy, DT; Wallace, RJ | 1 |
Donnelly, C; McDowell, S; McLaren, A; Williamson, R | 1 |
Ansorg, R; Fabry, W; Schmid, EN | 1 |
Ebe, T; Sato, K | 1 |
Nagai, H | 1 |
Kobashi, Y; Matsushima, T | 3 |
Forslöw, U; Geborek, A; Heurlin, N; Hjelte, L; Petrini, B | 1 |
Nakagawa, T; Ogawa, K; Taga, S; Tano, M | 1 |
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
Izumi, S; Taniguchi, H | 1 |
Furusyo, N; Hayashi, J; Murata, M; Ogawa, E; Ohnishi, H; Sawayama, Y; Tatsukawa, M | 1 |
Kobashi, Y; Oka, M | 1 |
Abass, KM; Adjei, O; Ampadu, EO; Awua-Boateng, NY; Awuah, PC; Bretzel, G; Nienhuis, WA; Schouten, JP; Siegmund, V; Stienstra, Y; Thompson, WA; Tuah, W; van der Werf, TS | 1 |
Billal, DS | 1 |
Jeon, K; Koh, WJ; Kwon, OJ; Park, HY; Sim, YS; Suh, GY | 1 |
Aïssi, E; Ettahar, N; Huleux, T; Massongo, M; Melliez, H; Pasquet, A; Yazdanpanah, Y | 1 |
Abe, M; Kato, S; Kobashi, Y; Mouri, K; Obase, Y; Oka, M | 1 |
Abass, MK; Abotsi, J; Amoako, YA; Asiedu, K; Forson, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M; Wilson, T | 1 |
Kingma, R; Klis, S; Stienstra, Y; Tuah, W; van der Werf, TS | 1 |
Abass, MK; Amoako, YA; Ampadu, E; Asiedu, K; Forson, M; Frimpong, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M | 1 |
Adamson, J; Converse, PJ; Grosset, JH; Kishi, Y; Li, SY; Nuermberger, EL; Tyagi, S; Xing, Y | 1 |
Chen, HC; Huang, CC; Huang, WC; Wu, MF | 1 |
Arar, D; Barisic, I; Goic-Barisic, I; Katalinic-Jankovic, V; Makek, MJ; Novak, A; Peric, I; Popovic, DR; Popovic, V; Rubic, Z; Tonkic, M | 1 |
Guarner, J | 1 |
Ishii, N; Richardson, M; Yotsu, RR | 1 |
Li, QF; Li, YJ; Liao, Y; Luo, J; Wang, DM; Wu, GH; Xu, YH; Zhong, J; Zhu, M | 1 |
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J | 1 |
Johnson, PDR | 1 |
Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T | 1 |
Abbass, A; Dzudzor, B; Gyamfi, E; Mosi, L; Narh, CA; Quaye, C | 1 |
5 review(s) available for clarithromycin and streptomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pulmonary infection due to Mycobacterium xenopi.
Topics: Bacterial Typing Techniques; Clarithromycin; Cycloserine; DNA Probes; Drug Resistance, Microbial; Gastrectomy; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections; Respiratory Tract Infections; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
[Nontuberculous mycobacteriosis].
Topics: Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pneumonia, Bacterial; Prognosis; Rifampin; Streptomycin | 2003 |
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.
Topics: Africa, Western; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Macrolides; Mycobacterium Infections; Mycobacterium ulcerans; Neglected Diseases; Polymerase Chain Reaction; Rifampin; Skin Diseases, Bacterial; Streptomycin | 2018 |
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
5 trial(s) available for clarithromycin and streptomycin
Article | Year |
---|---|
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Protein Synthesis Inhibitors; Rifabutin; Rifampin; Streptomycin; Treatment Outcome | 1996 |
[A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Time Factors; Treatment Outcome | 2000 |
The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Prospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2003 |
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Ghana; Humans; Injections, Intramuscular; Leprostatic Agents; Male; Mycobacterium ulcerans; Rifampin; Statistics, Nonparametric; Streptomycin; Time Factors; Treatment Outcome; Young Adult | 2010 |
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult | 2020 |
39 other study(ies) available for clarithromycin and streptomycin
Article | Year |
---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Aza Compounds; Clarithromycin; Colony Count, Microbial; Drug Combinations; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Quinolines; Rifampin; Streptomycin | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rifamycins; Streptomycin | 1995 |
Resistance to drugs targeting protein synthesis in mycobacteria.
Topics: Aminoglycosides; Bacterial Proteins; Base Sequence; Clarithromycin; Drug Resistance, Microbial; Molecular Sequence Data; Mutation; Mycobacterium; Peptides; Protein Structure, Secondary; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Streptomycin; Tetracyclines | 1994 |
The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions; Drug Resistance, Microbial; Helicobacter pylori; Histamine H2 Antagonists; Metronidazole; Ranitidine; Streptomycin | 1997 |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Fleroxacin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Child; Clarithromycin; Cohort Studies; Cystic Fibrosis; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Rifampin; Streptomycin | 2003 |
Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Outcome Assessment, Health Care; Practice Guidelines as Topic; Rifampin; Saliva; Sex Distribution; Streptomycin | 2004 |
[The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Ofloxacin; Radiography, Thoracic; Retrospective Studies; Streptomycin | 2005 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
[A case of Mycobacterium intracellulare infection with chronic empyema].
Topics: Aged, 80 and over; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Empyema; Ethambutol; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifampin; Streptomycin; Tomography, X-Ray Computed | 2006 |
The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Topics: Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Guideline Adherence; Humans; Incidence; Japan; Male; Middle Aged; Mycobacterium avium Complex; Retrospective Studies; Rifampin; Sputum; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
[AIDS-related Mycobacterium avium infection dissemination in a patient with endobronchial lesions associated with immune reconstitution inflammatory syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Bronchial Diseases; Bronchitis; Clarithromycin; Female; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Mycobacterium avium-intracellulare Infection; Streptomycin; Treatment Outcome | 2008 |
[Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Recurrence; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2008 |
Antimicrobial drugs for Buruli ulcer.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Ghana; Humans; Mice; Rifampin; Streptomycin | 2010 |
Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2010 |
[Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Axilla; Clarithromycin; Darunavir; Dideoxynucleosides; Enfuvirtide; Ethambutol; HIV Envelope Protein gp41; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Lamivudine; Lymph Node Excision; Lymphadenitis; Male; Mycobacterium avium-intracellulare Infection; Peptide Fragments; Pyrazinamide; Rifampin; Ritonavir; Streptomycin; Sulfonamides | 2011 |
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
Topics: Aged; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Ghana; Humans; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome | 2014 |
Compliance with antimicrobial therapy for buruli ulcer.
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin | 2014 |
Reply to "compliance with antimicrobial therapy for buruli ulcer".
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin | 2014 |
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
Topics: Animals; Buruli Ulcer; Clarithromycin; Clofazimine; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Therapy, Combination; Foot; Macrolides; Mice; Microbial Sensitivity Tests; Rifampin; Streptomycin; Survival Analysis; Time Factors; Treatment Outcome | 2015 |
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin | 2018 |
Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Croatia; Female; Humans; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Streptomycin; Treatment Outcome | 2018 |
Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Clarithromycin; Ethambutol; Female; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium Complex; Nontuberculous Mycobacteria; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Young Adult | 2019 |
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin | 2019 |
Buruli ulcer: cured by 8 weeks of oral antibiotics?
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Rifampin; Streptomycin | 2020 |
Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacillus; Bacteria; Buruli Ulcer; Candida; Clarithromycin; Coinfection; Cote d'Ivoire; Cross-Sectional Studies; Female; Fungi; Ghana; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillium; Staphylococcus; Streptomycin; Trichoderma; Watchful Waiting; Young Adult | 2021 |